Follow
Tara Lancaster
Tara Lancaster
Verified email at bham.ac.uk
Title
Cited by
Cited by
Year
Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection
AC Dowell, MS Butler, E Jinks, G Tut, T Lancaster, P Sylla, J Begum, ...
Nature immunology 23 (1), 40-49, 2022
1692022
Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study …
M Krutikov, T Palmer, G Tut, C Fuller, B Azmi, R Giddings, M Shrotri, ...
The Lancet Healthy Longevity 3 (1), e13-e21, 2022
892022
Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an …
G Tut, T Lancaster, M Krutikov, P Sylla, D Bone, N Kaur, E Spalkova, ...
The Lancet Healthy Longevity 2 (9), e544-e553, 2021
532021
COVID-19 vaccines elicit robust cellular immunity and clinical protection in chronic lymphocytic leukemia
H Parry, R Bruton, T Roberts, G McIlroy, S Damery, P Sylla, AC Dowell, ...
Cancer Cell 40 (6), 584-586, 2022
232022
Antibody and cellular immune responses following dual COVID-19 vaccination within infection-naive residents of long-term care facilities: an observational cohort study
G Tut, T Lancaster, P Sylla, MS Butler, N Kaur, E Spalkova, C Bentley, ...
The Lancet Healthy Longevity 3 (7), e461-e469, 2022
202022
S100P enhances the motility and invasion of human trophoblast cell lines
MEA Tabrizi, TL Lancaster, TM Ismail, A Georgiadou, A Ganguly, JJ Mistry, ...
Scientific Reports 8 (1), 11488, 2018
202018
Strong peak immunogenicity but rapid antibody waning following third vaccine dose in older residents of care homes
G Tut, T Lancaster, M Krutikov, P Sylla, D Bone, E Spalkova, C Bentley, ...
Nature Aging 3 (1), 93-104, 2023
132023
Children develop strong and sustained cross-reactive immune responses against spike protein following SARS-CoV-2 infection
AC Dowell, MS Butler, E Jinks, G Tut, T Lancaster, P Sylla, J Begum, ...
122021
Immunological imprinting of humoral immunity to SARS-CoV-2 in children
AC Dowell, T Lancaster, R Bruton, G Ireland, C Bentley, P Sylla, J Zuo, ...
Nature Communications 14 (1), 3845, 2023
82023
Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study …
M Krutikov, T Palmer, G Tut, C Fuller, B Azmi, R Giddings, M Shrotri, ...
72022
Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibody in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study …
M Krutikov, T Palmer, G Tut, C Fuller, B Azmi, R Giddings, M Shrotri, ...
medRxiv, 2021.09. 27.21264166, 2021
72021
Severe acute respiratory syndrome coronavirus 2 anti-spike antibody levels following second dose of ChAdOx1 nCov-19 or BNT162b2 vaccine in residents of long-term care …
O Stirrup, M Krutikov, G Tut, T Palmer, D Bone, R Bruton, C Fuller, B Azmi, ...
The Journal of Infectious Diseases 226 (11), 1877-1881, 2022
52022
Primary Omicron infection elicits weak antibody response but robust cellular immunity in children
AC Dowell, T Lancaster, R Bruton, G Ireland, C Bentley, P Sylla, J Zuo, ...
bioRxiv, 2022.07. 26.501570, 2022
52022
Robust SARS-CoV-2-specific and heterologous immune responses in vaccine-naïve residents of long-term care facilities who survive natural infection
G Tut, T Lancaster, MS Butler, P Sylla, E Spalkova, D Bone, N Kaur, ...
Nature Aging 2 (6), 536-547, 2022
52022
Booster vaccination strongly enhances SARS-CoV-2-specific antibody and cellular responses in elderly residents of care homes
G Tut, T Lancaster, M Krutikov, P Sylla, D Bone, E Spalkova, C Bentley, ...
52021
Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an …
G Tut, T Lancaster, M Krutikov, P Sylla, D Bone, N Kaur, E Spalkova, ...
DOI: https://doi. org/10.1016/S2666-7568 (21), 00168-9, 2021
52021
SARS-CoV-2 anti-spike antibody levels following second dose of ChAdOx1 nCov-19 or BNT162b2 in residents of long-term care facilities in England (VIVALDI)
O Stirrup, M Krutikov, G Tut, T Palmer, D Bone, R Bruton, C Fuller, B Azmi, ...
medRxiv, 2022.01. 26.22269885, 2022
22022
Reduced Antibody and Cellular Immune Responses Following Dual COVID-19 Vaccination Within Infection-Naïve Residents of Long-Term Care Facilities
G Tut, T Lancaster, MS Butler, D Bone, N Kaur, E Spalkova, C Bentley, ...
22021
The Role of the C-Terminal Lysine of S100P in S100P-Induced Cell Migration and Metastasis
TM Ismail, SR Gross, T Lancaster, PS Rudland, R Barraclough
Biomolecules 11 (10), 1471, 2021
22021
Children develop robust and sustained cross-reactive spike-specific immune responses following SARS-CoV-2 infection
AC Dowell, MS Butler, E Jinks, G Tut, T Lancaster, P Sylla, J Begum, ...
medRxiv, 2021.04. 12.21255275, 2021
12021
The system can't perform the operation now. Try again later.
Articles 1–20